Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Druzhestven N IzsledovatelskifiledCriticalDruzhestven N Izsledovatelski
Priority to BG8299788ApriorityCriticalpatent/BG48471A1/en
Publication of BG48471A1publicationCriticalpatent/BG48471A1/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The therapeutic means is intended for use in the prevention and the treatment of ischaemic disease of the heart in different forms and of spastic conditions affecting blood vessels, by exerting a potent and longer lasting influence on the pre-load and on the after-load of the heart, and having a reliable therapeutic effect with no significant individual deviations. The means contains isosorbite-2-mononitrate and isosorbite-5- mononitrate in a 1:1 or 1:3 ratios.
BG8299788A1988-02-161988-02-16Therapeutic means based on isosorbite mononitrate
BG48471A1
(en)